Not FDA-approved
Bones & muscles
GHRP-2
Evidence
Limited human data
Class
Growth hormone-releasing peptide
KEY TAKEAWAY
GHRP-2 is a synthetic six-amino-acid peptide that stimulates growth hormone release. It is also known as pralmorelin. GHRP-2 is not FDA-approved. A form called pralmorelin is approved in Japan as a diagnostic agent.
Written by the Veylo editorial team · Updated
November 2026
What it is
Growth hormone-releasing peptide
Main uses
Used in Japan as a diagnostic for growth hormone deficiency; sold online for body composition
Key fact
GHRP-2 is not FDA-approved. A form called pralmorelin is approved in Japan as a diagnostic agent.
Route
Subcutaneous injection
Evidence strength
Limited human data
GHRP-2 is a synthetic six-amino-acid peptide that stimulates growth hormone release. It is also known as pralmorelin.
It activates the ghrelin receptor in the pituitary gland and hypothalamus, which prompts growth hormone release and raises appetite.
GHRP-2 is not FDA-approved. A form called pralmorelin is approved in Japan as a diagnostic agent.
Used in Japan as a diagnostic for growth hormone deficiency; sold online for body composition.
Increased hunger, raised cortisol and prolactin, water retention and flushing are reported.
GHRP-2: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.